氯化4-(4,6-二甲氧基-1,3,5-三嗪-2-基)-4-甲基吗啉结构式
|
常用名 | 氯化4-(4,6-二甲氧基-1,3,5-三嗪-2-基)-4-甲基吗啉 | 英文名 | DMTMM |
|---|---|---|---|---|
| CAS号 | 3945-69-5 | 分子量 | 294.73 | |
| 密度 | N/A | 沸点 | N/A | |
| 分子式 | C10H19ClN4O4 | 熔点 | 110-114 °C | |
| MSDS | 中文版 美版 | 闪点 | 92.5 °C | |
| 符号 |
GHS05, GHS07 |
信号词 | Danger |
用途有机中间体 |
| 中文名 | 4-(4,6-二甲氧基三嗪-2-基)-4-甲基吗啉盐酸盐 |
|---|---|
| 英文名 | 4-(4,6-Dimethoxy-1,3,5-triazin-2-yl)-4-methyl morpholinium chloride |
| 中文别名 | 4-(4,6-二甲氧基-1,3,5,-三嗪-2-基)-4-甲基吗啉盐酸 | 氯化4-(4,6-二甲氧基-1,3,5-三嗪-2-基)-4-甲基吗啉 | 4-(4,6-二甲氧基三嗪)-4-甲基吗啉盐酸盐 | 4-(4,6-二甲氧基-2-均三嗪基)-4-甲基吗啉盐酸盐水合物 |
| 英文别名 | 更多 |
| 熔点 | 110-114 °C |
|---|---|
| 分子式 | C10H19ClN4O4 |
| 分子量 | 294.73 |
| 闪点 | 92.5 °C |
| 精确质量 | 294.73 |
| PSA | 75.59000 |
| 外观性状 | 白色粉末 |
| 储存条件 | -20℃ 避光,通风干燥处,密封保存 |
| 稳定性 | 常温常压下稳定 |
| 水溶解性 | 可溶于:甲醇 |
| 计算化学 | 1.疏水参数计算参考值(XlogP):无 2.氢键供体数量:0 3.氢键受体数量:7 4.可旋转化学键数量:3 5.互变异构体数量:无 6.拓扑分子极性表面积66.4 7.重原子数量:18 8.表面电荷:0 9.复杂度:236 10.同位素原子数量:0 11.确定原子立构中心数量:0 12.不确定原子立构中心数量:0 13.确定化学键立构中心数量:0 14.不确定化学键立构中心数量:0 15.共价键单元数量:2 |
| 符号 |
GHS05, GHS07 |
|---|---|
| 信号词 | Danger |
| 危害声明 | H302-H314 |
| 警示性声明 | P280-P305 + P351 + P338-P310 |
| 个人防护装备 | Eyeshields;Faceshields;full-face particle respirator type N100 (US);Gloves;respirator cartridge type N100 (US);type P1 (EN143) respirator filter;type P3 (EN 143) respirator cartridges |
| 危害码 (欧洲) | C:Corrosive; |
| 风险声明 (欧洲) | R20/21/22;R34;R40 |
| 安全声明 (欧洲) | S26-S36/37/39-S45 |
| 危险品运输编码 | UN 3261 8/PG 2 |
| WGK德国 | 3 |
| 包装等级 | III |
| 危险类别 | 8 |
| 海关编码 | 2934999090 |
|
~98%
氯化4-(4,6-二甲氧基-1... 3945-69-5 |
| 文献:Hirano, Naoki; Saijyo, Masako Patent: US2003/153785 A1, 2003 ; |
|
~99%
氯化4-(4,6-二甲氧基-1... 3945-69-5 |
| 文献:Kolesinska, Beata; Kasperowicz, Katarzyna; Sochacki, Marek; Mazur, Adam; Jankowski, Stefan; Kaminski, Zbigniew J. Tetrahedron Letters, 2010 , vol. 51, # 1 p. 20 - 22 |
|
~%
详细
|
| 文献:Kunishima, Munetaka; Ujigawa, Takae; Nagaoka, Yoshie; Kawachi, Chiho; Hioki, Kazuhito; Shiro, Motoo Chemistry - A European Journal, 2012 , vol. 18, # 49 p. 15856 - 15867 |
| 海关编码 | 2934999090 |
|---|---|
| 中文概述 | 2934999090. 其他杂环化合物. 增值税率:17.0%. 退税率:13.0%. 监管条件:无. 最惠国关税:6.5%. 普通关税:20.0% |
| 申报要素 | 品名, 成分含量, 用途 |
| Summary | 2934999090. other heterocyclic compounds. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0% |
|
Monoclonal antibody-functionalized multilayered particles: targeting cancer cells in the presence of protein coronas.
ACS Nano 9(3) , 2876-85, (2015) Engineered particles adsorb biomolecules (e.g., proteins) when introduced in a biological medium to form a layer called a "corona". Coronas, in particular the protein corona, play an important role in... |
|
|
Relative quantification of amine-containing metabolites using isobaric N,N-dimethyl leucine (DiLeu) reagents via LC-ESI-MS/MS and CE-ESI-MS/MS.
Analyst 140(2) , 467-75, (2014) Tandem mass spectrometry (MS/MS)-based relative quantification by isobaric labeling is a useful technique to compare different metabolic expression levels in biological systems. For the first time, we... |
|
|
Peptide dimethylation: fragmentation control via distancing the dimethylamino group.
J. Am. Soc. Mass Spectrom. 25(10) , 1694-704, (2014) Direct reductive methylation of peptides is a common method for quantitative proteomics. It is an active derivatization technique; with participation of the dimethylamino group, the derivatized peptid... |
| 4-(4,6-Dimethoxy-[1,3,5]triazin-2-yl)-4-methylmorpholin-4-ium chloride |
| DMTMM |
| T6N CN ENJ BO1 DO1 F- AT6K DOTJ A1 &&Cl- |
| 4-(4,6-Dimethoxy[1,3,5]triazin-2-yl)-4-methylmorpholinium chloride |
| 4-(4,6-Dimethoxy-1,3,5-triazin-2-yl)-4-methylmorpholin-4-ium |
| 4-(4,6-Dimethoxy[1.3.5]triazin-2-yl)-4-methylmorpholinium chloride |
| KUNISHIMA COUPLING REAGENT |
| MFCD03093287 |
| 4-(4,6-Dimethoxy-1,3,5-triazin-2-yl)-4-methylmorpholinium Chloride |
| 4-(4,6-Dimethoxy-1,3,5-triazine-2-yl)-4-methyl morpholinium chloride |
| 4-(4,6-Dimethoxy-1,3,5-triazin-2-yl)-4-methylmorpholin-4-ium chloride |
| DMTMM Cl |
| 4-4-methylmorpholinium chloride |
| EINECS 447-230-1 |
| Morpholinium, 4-(4,6-dimethoxy-1,3,5-triazin-2-yl)-4-methyl-, chloride (1:1) |
| 4-(4,6-DIMETHOXY-1,3,5-TRIAZIN-2-YL)-4-METHYLMORPHOLINIUM CH LORIDE |